Maxime Bucci
Lille, 59000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
NPM1 mutation subtype switch in acute myeloid leukemia.
Journal: Haematologica
Published: November 06, 2024
Multi-target measurable residual disease assessed by error-corrected sequencing in patients with acute myeloid leukemia: An ALFA study.
Journal: Blood cancer journal
Published: April 03, 2024
Publisher Correction: Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3r.
Journal: BMC bioinformatics
Published: December 10, 2022
Hematopoietic differentiation at single-cell resolution in NPM1-mutated AML.
Journal: Blood cancer journal
Published: August 12, 2022
Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3r.
Journal: BMC bioinformatics
Published: June 02, 2022
Clinico-Biological Features and Clonal Hematopoiesis in Patients with Severe COVID-19.
Journal: Cancers
Published: June 30, 2020
Clinical relevance of IDH1/2 mutant allele burden during follow-up in acute myeloid leukemia. A study by the French ALFA group.
Journal: Haematologica
Published: October 29, 2017
Comprehensive mutational profiling of core binding factor acute myeloid leukemia.
Journal: Blood
Published: December 23, 2015
Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemia.
Journal: Leukemia
Published: August 29, 2015
Unlike ASXL1 and ASXL2 mutations, ASXL3 mutations are rare events in acute myeloid leukemia with t(8;21).
Journal: Leukemia & lymphoma
Published: April 10, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026